Sellas Life Sciences Group, Inc.
Pharmaceutical Preparations · New York, NY, United States
- PrincipalsAngelos M. StergiouPresident and CEODragan CicicSVP, Chief Development OfficerJohn Thomas BurnsCFOand 5 more
- CompanySellas Life Sciences Group, Inc.New York, NY, United States
- Phone line+1 (646) 200-5278General business
SELLAS Life Sciences Group, Inc. is an SEC-registered Nasdaq-listed company (ticker SLS) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 8
Chief executive
Angelos M. StergiouPresident and CEO
Chair & board
David A ScheinbergDirector (Board)
Jane WasmanDirector (Board)
John VarianDirector (Board)
Katherine Bach KalinDirector (Board)
Finance
Everyone else on file (1)
Dragan CicicSVP, Chief Development Officer
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Dragan Cicic — SVP, Chief Development Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗John Thomas Burns — CFO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗David A Scheinberg — Director (Board)
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Angelos M. Stergiou — President and CEO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Silence Therapeutics plcPharmaceutical Preparations · London1 shared capabilityEdesa Biotech, Inc.Pharmaceutical Preparations · Markham1 shared capabilityAmneal Pharmaceuticals, Inc.Pharmaceutical Preparations1 shared capabilityKiniksa Pharmaceuticals International, plcPharmaceutical Preparations · London1 shared capabilityXenon Pharmaceuticals Inc.Pharmaceutical Preparations · Burnaby1 shared capabilityAmarin Corp PLC\UKPharmaceutical Preparations · Dublin 21 shared capabilityPluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capabilityJazz Pharmaceuticals plcPharmaceutical Preparations · Dublin1 shared capability